scCoV2-Einzelsequenzierung von SARS-CoV2-infizierten Zellen

  • Funded by Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
  • Total publications:1 publications

Grant number: 01KI20269

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $54,122.39
  • Funder

    Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
  • Principle Investigator

    Pending
  • Research Location

    Germany, Europe
  • Lead Research Institution

    Max-Delbrück-Centrum für Molekulare Medizin, Berlin
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    Gender

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

discovery - This is a basic scientific research project on SARS-CoV-2. The aim of the project is to investigate in detail the mutual influences between the viruses and the metabolism of human host cells in SARS-CoV-2 infection. Specifically, the ribonucleic acids (RNA) of individual cells from cell lines infected with SARS-CoV-2 are to be examined (sequenced) and analyzed in detail in the project. Based on the findings, cell culture models are to be developed that can be used for further questions on SARS-CoV-2 infections.

Publicationslinked via Europe PMC

Last Updated:39 minutes ago

View all publications at Europe PMC

Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy.